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Abstract The purpose of the study is to test the cross-
cultural adaptation and psychometric properties of a Dan-
ish version of the Headache-Specific Locus of Control
Scale (HSLC) and the Headache Management Self-Effi-
cacy Scale (HMSE) in a tertiary headache centre. HSLC
and HMSE are headache-specific measures of locus of
control (LOC) and SE. The Danish versions of the HSLC
and the HMSE were created according to the guidelines for
cross-cultural adaptation of self-report measures. The
HSLC and HMSE were administered to 135 consecutively
referred headache patients in a tertiary headache centre
together with other self-report measures concerning gen-
eral distress, anxiety, depression, and health-related quality
of life. Internal stability of the HSLC subscales and the
HMSE were analysed using Chronbach’s a coefficient. The
psychometric properties of the Danish version of the HSLC
and the HMSE were analysed using Spearman’s rank
correlation test. Cronbach’s a ranged from 0.71 to 0.88 and
the corrected item-total correlations were acceptable. The
mean corrected item-total correlations for the three sub-
scales of HSLC (health-care LOC, internal LOC, and
chance LOC) were 0.40, 0.59, and 0.40 respectively. The
mean corrected item-total correlation for HMSE was 0.42.
High HMSE scores were found to be associated with high
scores on internal LOC and low scores on chance LOC.
High scores on chance LOC were positively associated
with low scores on social functioning independently of
headache frequency. The results are consistent with the
earlier findings of the original American versions of HMSE
and HSLC. These scales seem to be valid and valuable
tools for testing of psychological aspects related to level of
functioning and quality of life for headache patients across
different cultures of Western society. The HMSE and the
HSLC proved valuable in clinical headache research. Since
scores on HSLC and HMSE were associated with measures
of physical and social functioning the HSLC and HMSE
may be of particular interest for intervention studies aimed
at enhancing level of functioning for headache patients.
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Introduction
Psychological treatment strategies with relaxation, bio-
feedback, and/or cognitive therapy have been demonstrated
to be effective in patients with migraine or tension-type
headache [1–4]. However, not all patients seem to profit
from psychological treatment and because of the variable
response, interest has focused on the identification of pre-
dicting factors influencing treatment outcome. Several
authors have proposed that psychological factors, e.g. locus
of control (LOC) [5, 6], catastrophizing [7, 8], self-efficacy
(SE) [9–11], and affective, mood and personality disorders
[12–14], may influence both the pain intensity, frequency,
headache impact and treatment outcome.
The definition of LOC is a patient’s perception of factors
influencing the pain, meaning to what extent the patient
perceives that internal (own) or external (e.g. significant
others or fate) factors are controlling the pain [15].
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For pain patients, LOC has been shown to be related to
pain coping style and treatment response and it has been
reported that it is the specific pattern of LOC that is
essential rather than just the scale with the highest score
[15].
The definition of pain-related SE is a patient’s confi-
dence in his or hers abilities to influence the pain. Headache
SE has been shown to be related to increased use of positive
psychological coping strategies and reduction of anxiety
[9] and to reduce the negative influence of stressful events
on headache frequency [16]. A study of moderators and
mediators of treatment outcome for persons with chronic
tension-type headache showed, that, the treatment effect
measured by headache activity for stress-management
therapy alone and combined with antidepressant medication
respectively were fully mediated by SE measured by
Headache Management Self-Efficacy Scale (HMSE) [11].
The mediator effect of SE on outcome measured by head-
ache disability was reduced to a third at most when a mood
or anxiety disorder was present for both stress-management
therapy alone and combined with antidepressant medication
even though headache disability was significantly improved
by both the treatments [11]. There was little or no mediator
effect of SE for antidepressant medication alone [11]. Nash
and Bach [17] found that higher SE for headache was
associated with lower headache-related disability indepen-
dent of headache frequency. A study by Rokicki et al. [18]
indicated that the positive outcome of EMG biofeedback
training could be related to changes in headache-related SE.
The headache management SE scale is a four-item measure
with each item matching one of four headache self-man-
agement behaviours and Bond et al. [10] found that a group
of patients exposed to a 48 min videotape (content: head-
ache education, effective use of headache medications,
cognitive-behavioural stress management and stretching-
based muscle relaxation) had significantly higher headache
management SE scores than a waiting list group. These
results, thus, indicate the importance in behavioral head-
ache treatment of measuring SE for both research and
clinical purposes.
A study by Martin et al. [5] indicated that the Headache-
Specific Locus of Control Scale (HSLC) accounted for
variance in measures of depression, physical symptoms,
disability, catastrophizing, medication use, and treatment
preferences not accounted for by a measure of general
LOC. These findings point to the need for headache-spe-
cific measures of LOC and SE. The HSLC [5] and HMSE
[9] were selected since they to the best of our knowledge
are the only headache-specific measures of the concepts of
LOC and SE for which psychometric properties have been
established.
Guillemin et al. [19] propose amongst others that the
simple translation of a measure into another language is
insufficient to obtain a valid version of the original version
due to language and cultural differences. Bullinger et al.
[20] also suggest evaluation of the psychometric properties
of the translated version in order to secure cross-culturally
comparable translations of surveys.
The aim of the present study was, therefore, to translate
the HSLC and HMSE into Danish according to the pro-
posed guidelines and investigate the reliability and validity
of the Danish version by comparing findings with the
Danish versions with the results from the original studies
[5, 9]. The final version of the Danish translation is pre-
sented and applied as a reference material for headache
patients in a tertiary referral centre.
Methods
Patients referred to the Danish Headache Centre (DHC)
were diagnosed according to the International Classifica-
tion Headache Disorders, 2nd edition criteria [21] by
experienced neurologists. Diagnoses were based on a
1-month headache diary, a structured interview, a clinical
examination and para clinical tests when necessary.
Patients who received a headache diagnosis were consec-
utively included. The DHC is the only national tertiary
headache referral centre and offer multidisciplinary treat-
ment strategies [22]. The period of inclusion ran from
March to June 2003. HSLC, HMSE, symptom check list-
90-R (SCL-90 R), the medical outcomes study short-form
questionnaire (SF-36), Beck’s depression inventory (BDI)
and Beck’s anxiety inventory (BAI) were administered to
the patients by a trained psychologist at their first visit at
the DHC. Exclusion criteria were insufficient knowledge of
Danish language or the patient lacking time.
The HSLC and HMSE were translated forward and
backward using guidelines for cross-cultural adaptation
provided by Beaton et al. [23].
Headache activity was based on the headache frequen-
cies derived from the detailed diagnostic headache diaries
[22]. Medication use was calculated in defined daily doses
recommended by WHO [24] based on the information
derived from the headache diaries regarding drugs and
doses for three categories (over the counter analgesics,
abortive migraine medication, and opiates).
Sick leave due to headache was based on patient’s self-
reported information prior to the first visit to the clinic.
The HSLC is a 33-item scale (5-point Likert’s scale,
1 = strongly disagree to 5 = strongly agree). The scale
includes three subscales measuring internal (own) and
external [significant others (health-care professionals) and
chance] LOC. In the original study, it was shown that
HSLC predicts medication consumption, psychological
consequences of headache episodes (e.g. depression and
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headache-related disability) and preference for treatment
modality even when controlling for headache severity
(frequency and intensity) in a sample of college students
with recurrent headaches [5]. A replication study found
similar psychometric characteristics for the HSLC sub-
scales when applied to patients at a headache clinic [6].
The HMSE is a 25-item scale (7-point Likert’s scale,
1 = strongly disagree to 7 = strongly agree). The scale
measures the SE, i.e. ‘‘an individual’s perception that they
can engage in behaviors that will prevent or manage their
recurrent headaches’’ [9]. The HMSE score predicts
headache-related disability also when controlling for
headache severity and HSLC scores [9].
The SCL-90-R is a 90-item self-report measure of psy-
chological symptom patterns. Items are scored on a 5-point
scale (0 = not at all to 4 = extremely) according to how
much discomfort the symptom caused during the last week.
The original version consists of nine subscales and three
summary indices: general symptomatic index (GSI), posi-
tive symptom distress level, and positive symptom total.
Some cross-cultural validation studies have only found
support for the GSI, since all subscales were highly cor-
related [25, 26]. A Danish version of the SCL-90-R has
shown satisfying reliability and validity [27].
The SF-36 is a 36-item self-report measure of health-
related quality of life. It consists of five scales measuring
dysfunction [physical functioning (PF), role physical (RP),
role emotional (RE), social functioning (SF) and bodily
pain (BP)] and three scales measuring negative as well as
positive aspects of health [mental health (MH), vitality
(VT) and general health (GH)]. Furthermore, it is possible
to calculate two summary scales: the physical component
summary for the four subscales (PF, RP, BP, and GH)
primarily measuring physical health, and the mental com-
ponent summary for the four subscales (VT, SF, RE, and
MH) primarily measuring mental health [28, 29]. On all
scales, high scores reflect good health status. The scales
differ with regard to number of items, reply possibilities
and levels [30]. The Danish version of the SF-36 has
demonstrated good internal consistency and homogeneity
[31] and has been tested in a representative sample
(n = 4,080) from the general Danish population [30].
The BDI and the BAI are 21-item self-report measures of
depression and anxiety, respectively. The items of both
measures are scored on a 4-point scale (0 = not at all to
3 = severely). The BDI measures intensity of depression. It
is used worldwide and has been shown to reliably distinguish
between depressed and non-depressed individuals [32]. The
BAI is intended to asses the severity of symptoms of anxiety
minimally shared with depression [33–35]. Enns et al. [36]
concluded that BDI and BAI assess distinct symptoms of
depression and anxiety in clinically depressed samples.
Statistics
Internal stability of the HSLC subscales and the HMSE
were analysed using Chronbach’s a coefficient. The
psychometric properties of the HSLC and the HMSE
were analysed using Spearman’s rank correlation test with
0.05 and 0.01 as significance level (2-tailed). Possible
differences across headache diagnoses (MIG, TTH,
MIG ? TTH, and MOH) and gender were analysed using
Mann–Whitney pair-wise tests with 0.05 as significance
level (2-tailed). Possible differences between the scores of
the sample of patients from a tertiary multidisciplinary
headache centre and the scores of a representative sample
from the Danish population on the eight subscales of SF-36
and GSI from SCL-90 were analysed using the Student’s t
test with 0.01 as significance level (2-tailed).
Results
A total of 135 patients were included. The number of
patients included in the calculations varies due to missing
values. The mean age was 44 years (SD = 13.7, range =
15–75) and 75% were women. The average patient had 20
headache days/month (2–30), consumed 30 standard doses
of abortive medicine (analgesics and triptans)/month
(0–220), and had five absence days due to headache/month
(0–30). There were no gender differences amongst the
clinical characteristics. Headache diagnoses and headache
data for the different diagnostic groups and basic descrip-
tive statistics for the study measures are shown in Tables 1
and 2, respectively. There were no significant differences
in scores for HMSE and the three subscales of HSLC
across gender and the larger groups of headache diagnoses
(MIG, TTH, TTH ? MIG, and MOH), except for the
MOH patients having significantly (P = 0.045) higher
scores on the internal LOC scale than patients with both
TTH and MIG.
The included headache patients scored consistently and
significantly (P \ 0.005 for all scales) lower than a rep-
resentative sample from the general Danish population [30]
on all SF-36 subscales (Fig. 1).
The level of psychological distress as measured by GSI
was slightly, but significantly (P \ 0.01) higher for the
headache patients than for a representative sample from the
general Danish population [37]. 27% of our headache
patients reported general distress above the national norm
based cut-off score for clinical level of general distress
compared with 17.5% in the general Danish population
sample [37].
The HMSE and the subscales of HSLC showed good
internal consistency (Cronbach’s a ranging from 0.71 to
J Headache Pain (2009) 10:341–347 343
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0.88) and acceptable corrected item-total correlation
(Table 3).
Construct validity of the HMSE and HSLC was
assessed by examination of associations between the two
scales and measures of health-related quality of life
(SF-36) and psychological distress (BDI, BAI, and SCL-
90). Intercorrelations for the study measures are presented
in Table 4.
High HMSE scores were found to be associated with
high scores on internal LOC and low scores on chance
LOC. High scores on HMSE had small, but significant
correlations with low scores on GSI and BDI, and high
scores on PF. The opposite correlations were found for
headache frequency. There was no significant correlation
between HMSE and headache frequency.
High scores on chance LOC were positively associated
with low scores on SF independently of headache
frequency.
Table 1 Headache characteristics in 129 consecutive patients (diagnoses, frequency, acute medication, and absence days due to headache)
Headache diagnosis N Frequency Medication use (DDD) Absence of work
Migraine only 13 7 (3–12) 11 (0–32) 4 (0–30)
TTH only 17 28 (9–30) 22 (0–60) 9 (0–30)
MIG and TTH 43 14 (2–30) 14 (0–47) 2 (0–30)
MOH 35 23 (4–30) 62 (0–220) 4 (0–30)
CPTH 7 24 (9–30) 12 (0–50) 14 (0–30)
CH 5 16 (3–30) 12 (0–35) 8 (0–30)
OTHERa 9 24 (7–30) 44 (0–135) 3 (0–14)
Data are presented as mean days/month (ranges in brackets)
TTH tension-type headache, MIG migraine, MOH medication-overuse headache, CPTH chronic post-traumatic headache, CH cluster headache,
DDD defined daily doses
a Primarily headache attributed to non-vascular intracranial disorder and primary facial pain
Table 2 Descriptive statistics
for test scores of the study
measures (values from the
original study of HMSE [9] in
square brackets [ ])
HSLC Headache-Specific Locus
of Control Scale, HMSE
Headache Management Self-
Efficacy Scale, DDD defined
daily doses, BDI Beck’s
depression inventory,
BAI Beck’s anxiety inventory,
GSI global severity index,
PCS physical component score,
PF physical function,
GH general health,
MCS mental component score,
SF social functioning
a The number of patients
included in the calculations
varies due to missing values
Measure Mean (SD) Range No. of patientsa
HMSE 91.7 (25.1) [110.3 (20.9)] 32–154 [48–163] 133
HSLC
Internal 34.2 (9.9) [36.4 (8.0)] 11–55 [11–52] 135
Chance 35.0 (8.9) [30.9 (8.1)] 15–68 [13–51] 133
Professional 28.4 (7.0) [28.9 (6.2)] 11–46 [11–47] 133
Headache frequency (days/month) 20 2–30
Medication use (DDD/month) 30 0–220
BDI 8.7 (6.9) [9.1 (7.0)] 0–31 [0–35] 133
BAI 8.0 (7.9) 0–32 122
GSI (SCL-90-R) 0.58 (0.47) 0.03–2.17 135
SF-36
PCS 40.4 (9.4) 12–58 135
PF 80.3 (21.0) 0–100 135
GH 56.7 (21.8) 0–100 135
MCS 48.4 (9.1) 19–64 135
SF 70.5 (23.9) 13–100 135
Fig. 1 SF-36 scores (mean) for headache patients (HP) (n = 135)
and a Danish population sample (PS) (n = 4,080) [30]. PF physical
function, RP role physical, BP bodily pain, GH general health, VT
vitality, SF social functioning, RE role emotional, MH mental health;
*P \ 0.005
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Discussion
The present results suggest that the Danish versions of
HMSE and HSLC are both reliable and valid measures of
headache-specific SE and LOC with psychometric prop-
erties equal to those described in the original reports [5, 9]
and a subsequent study [6]. The Danish versions of HMSE
and HSLC have acceptable values for Cronbach’s a and
item-total correlations when tested in a sample of headache
patients from a tertiary headache centre. We also identified
significant correlations between HMSE and HSLC scores
and measures of depression, anxiety, general psychopa-
thology, and health-related quality of life corresponding
with the original studies [5, 9] even though different
measures were employed. The results thus further support
the validity of the concepts of headache-specific SE and
LOC across different cultures of Western society.
We found a minor, but significant positive correlation
between high headache-specific SE and good PF and low
general psychological distress. Headache frequency did not
correlate significantly with headache-specific SE, but had
minor significant negative correlations with good physical
function and low general psychological distress. Patients
with high HMSE scores thus have better physical and SF
and less symptoms of psychological distress. Similar results
are reported in another study of SE and headache [16].
The reference material presented consists of patients
consecutively referred to a tertiary referral headache
centre and thus should be representative for patients
seen in specialist headache centres. These psychological
Table 3 Item correlations with
scale scores and Cronbach’s a
for HSLC and HMSE items
(values from original studies
[5, 9] in brackets)
HSLC Headache-Specific Locus





Corrected item-total correlation Cronbach’s a
Mean Range
HSLC
Health-care professional (n = 133) 0.52 0.40 0.30–0.59 0.75 (0.88)
Internal (n = 135) 0.13 0.59 0.35–0.74 0.88 (0.86)
Chance (n = 133) 0.32 0.40 0.18–0.54 0.71 (0.84)
HMSE (n = 135) 0.35 0.42 (0.49) 0.058–0.611 (0.27–0.66) 0.85 (0.90)
Table 4 Correlation between HSLC and HMSE subscales and other measures (BDI, BAI, SCL-90 GSI), selected SF-36 subscales, and headache
frequency (HF)
HMSE HSLC HF BDI BAI GSI SF-36





Pro 0.01 0.16 0.18*
HF -0.16 0.02 0.35** -0.11
BDI -0.28** 0.22* 0.27** 0.19* 0.30**
BAI -0.18 0.11 0.23* 0.26** 0.08 0.60**
GSI -0.22* 0.25** 0.28** 0.18 0.27** 0.79** 0.72**
SF-36
PCS 0.13 -0.11 -0.19* -0.08 -0.25** -0.34** -0.11 -0.70**
PF 0.18* -0.10 -0.18* -0.08 -0.22* -0.50** -0.20* -0.41** 0.68**
GH 0.21* -0.21 -0.29** -0.23** -0.39** -0.59** -0.42** -0.54** 0.54** 0.54**
MCS 0.20* -0.09 -0.29** -0.09 -0.23* -0.71** -0.60** -0.70** 0.16 0.35** 0.43**
SF 0.18* -0.06 -0.20* -0.09 -0.13 -0.47** -0.26** -0.37** 0.55** 0.46** 0.38** 0.51**
HSLC Headache-Specific Locus of Control Scale, HMSE Headache Management Self-Efficacy Scale, HF headache frequency, BDI Beck’s
depression inventory, BAI Beck’s anxiety inventory, GSI global severity index, PCS physical component score, PF physical function, GH general
health, MCS mental component score, SF social functioning
* P \ 0.05
** P \ 0.01 (2-tailed)
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characteristics can be used as a reference material for the
treatment of patients with rare headache diagnoses or
headaches difficult to treat as well as baseline values for
future treatment studies. The present reference material
may, however, not be representative for the general head-
ache population, as they are highly selected and charac-
terised as having refractory or rare headache before they
are referred.
Headache data consisted of frequencies only and more
precise data (duration and intensity) may yield more
information into the correlations between LOC and SE
scores and headache activity.
The HMSE and the HSLC may help identifying patients
with special needs for non-pharmacological treatment in a
multidisciplinary headache centre, since headache-specific
SE were found to correlate with general psychological
distress, symptoms of depression, and physical function.
The concepts of headache-specific SE and LOC may also
be helpful in identifying possible mediators or moderators
of non-pharmacological headache treatment [18]. The
findings in the present study indicate that the Danish
versions of HMSE and the HSLC are reliable and valid
measures of the two concepts and we recommend the use
of them in future studies of headache-specific LOC
and SE.
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